Kim Magdich

Kimberly Magdich is a seasoned professional in pharmacovigilance with extensive experience in monitoring and assessing the safety profiles of both developmental and marketed products. Currently serving as Senior Director of Pharmacovigilance at BridgeBio since May 2023, Kimberly previously held key positions at Emergent BioSolutions, where roles included Director and Senior Manager of Pharmacovigilance. Other significant experiences include working as a Safety Scientist at Astellas Pharma US and as a Senior Pharmacovigilance Specialist at Emergent BioSolutions. Kimberly's career began in nursing, with roles in critical care and cardiac telemetry, including positions at Allegiance Health and Oakwood Hospital & Medical Center. Kimberly holds a Bachelor of Science in Nursing from Madonna University and an Associate's Degree in Natural Science from Henry Ford College.